Tania Fleitas Kanonnikoff (@tfleitask) 's Twitter Profile
Tania Fleitas Kanonnikoff

@tfleitask

Medical Oncologist MD, PhD. HCUV. Incliva Biomedical Research Institute

ID: 940705895562072064

calendar_today12-12-2017 22:12:17

1,1K Tweet

731 Followers

1,1K Following

Tania Fleitas Kanonnikoff (@tfleitask) 's Twitter Profile Photo

Second day of AIDA EU project GAM in London. Very motivating to see such great progress on our project looking forward for improving #gastriccancerprevention . Thanks to all partners for your great efforts and to the team of Imperial College London for hosting us so kind.

Second day of <a href="/AIDAeuproject/">AIDA EU project</a> GAM in London. Very motivating to see such great progress on our project looking forward for improving #gastriccancerprevention . Thanks to all partners for your great efforts  and to the team of <a href="/imperialcollege/">Imperial College London</a>  for hosting us so kind.
AIDA EU project (@aidaeuproject) 's Twitter Profile Photo

📢 AIDA General Assembly 2025 in London has successfully concluded! Huge thanks to Imperial College London for hosting us. Over two days, we reflected on progress and planned next steps in gastric cancer research. Grateful to all partners for their dedication!

Tania Fleitas Kanonnikoff (@tfleitask) 's Twitter Profile Photo

Today is a special day for LEGACyH2020 project! We are proud Tessa Groen-van Schooten defended her Phd entitled "Defining heterogeneity in the immune infiltrate of gastroesophageal adenocarcinoma". Special thanks to co-supervisors Sarah Derks and Tanja de Gruijl .

Today is a special day for <a href="/LegacyH2020/">LEGACyH2020</a> project! We are proud Tessa Groen-van Schooten defended her Phd entitled "Defining heterogeneity in the immune infiltrate of gastroesophageal adenocarcinoma". Special thanks to co-supervisors Sarah Derks and Tanja de Gruijl .
Tania Fleitas Kanonnikoff (@tfleitask) 's Twitter Profile Photo

It is my great pleasure to share this podcast featuring a clinical case discussion with outstanding experts. A truly insightful and enriching experience! sciencedirect.com/science/articl…. Stay tuned for more insightful episodes from the ESMO - Eur. Oncology experts!

AIDA EU project (@aidaeuproject) 's Twitter Profile Photo

🇪🇸 ¡Próximamente! El proyecto europeo AIDA para combatir el cáncer gástrico, organiza un curso gratuito con 3 webinars enfocados a la "Prevención del cáncer gástrico". 📅 Cuándo: 12.06, 19.06, 26.06 💻Regístrate: linktr.ee/AIDA_EU

🇪🇸 ¡Próximamente!
El proyecto europeo AIDA para combatir el cáncer gástrico, organiza un curso gratuito con 3 webinars enfocados a la "Prevención del cáncer gástrico".
📅 Cuándo: 12.06, 19.06, 26.06
💻Regístrate: linktr.ee/AIDA_EU
AIDA EU project (@aidaeuproject) 's Twitter Profile Photo

📢 ¡Mañana a las 14h (hora España) empieza el primer webinar AIDA! Hablamos sobre cáncer gástrico con la Dra. Camargo y Dra. Fleitas, con ponencias interactivas. 📝 Regístrate en el enlace de la bio. ¡Te esperamos! Hospital Clínic INCLIVA

📢 ¡Mañana a las 14h (hora España) empieza el primer webinar AIDA! 
Hablamos sobre cáncer gástrico con la Dra. Camargo y Dra. Fleitas, con ponencias interactivas.
📝 Regístrate en el enlace de la bio. ¡Te esperamos! <a href="/hospitalclinic/">Hospital Clínic</a> <a href="/incliva_iis/">INCLIVA</a>
AIDA EU project (@aidaeuproject) 's Twitter Profile Photo

📢 Mañana sigue la serie de webinars AIDA Tema: Diagnóstico y tratamiento de Helicobacter pylori 🕑 14h (España) Con Samuel Martínez, J. Tejedor y M. Sánchez Modera J.P. Gisbert ¡No te lo pierdas! Hp-EuReg 💊 Hospital Clínic

📢 Mañana sigue la serie de webinars AIDA
Tema: Diagnóstico y tratamiento de Helicobacter pylori
🕑 14h (España)
Con Samuel Martínez, J. Tejedor y M. Sánchez
Modera J.P. Gisbert
¡No te lo pierdas! <a href="/hpeureg/">Hp-EuReg 💊</a> <a href="/hospitalclinic/">Hospital Clínic</a>
AIDA EU project (@aidaeuproject) 's Twitter Profile Photo

🔍 La próxima semana cierra nuestra serie de webinars AIDA Tema: Lesiones precursoras del cáncer gástrico 🕑 14h (España) Con Cuatrecasas, Fernández-Esparrach y Moreira Modera: L. Moreira ¡Te esperamos!

🔍 La próxima semana cierra nuestra serie de webinars AIDA
Tema: Lesiones precursoras del cáncer gástrico
🕑 14h (España)
Con Cuatrecasas, Fernández-Esparrach y Moreira
Modera: L. Moreira
¡Te esperamos!
DailyHealthcareAI (@aipulserx) 's Twitter Profile Photo

Can artificial intelligence outperform human clinicians in selecting personalized treatments for the world's most common carcinogenic infection that affects nearly half the global population?Nature Communications UAM Autónoma Madrid "The Helicobacter pylori AI-clinician harnesses artificial

Can artificial intelligence outperform human clinicians in selecting personalized treatments for the world's most common carcinogenic infection that affects nearly half the global population?<a href="/NatureComms/">Nature Communications</a> <a href="/UAM_Madrid/">UAM Autónoma Madrid</a> 

"The Helicobacter pylori AI-clinician harnesses artificial
Jeroen Dekervel (@jdekervel) 's Twitter Profile Photo

🎧 New ESMO - Eur. Oncology upper GI podcast! We unpack key #ASCO25 updates in #PancreaticCancer & #BiliaryCancer: ✔️ CASSANDRA ✔️ PANOVA-3 ✔️ Elraglusib ✔️ GAIN & POLCA-GB w/ Arndt Vogel & Florian Castet 🎙 Listen: open.spotify.com/episode/47uQnC… #GIonc

AIDA EU project (@aidaeuproject) 's Twitter Profile Photo

🚀 New research in Nature Communications explores how AI can optimise H. pylori eradication strategies using real-world clinical data from Hp-EuReg 💊. A step forward for precision, data-driven medicine. Read more 👉 doi.org/10.1038/s41467…

Jeroen Dekervel (@jdekervel) 's Twitter Profile Photo

🎧 Another ESMO - Eur. Oncology Upper GI podcast! We break down key #ASCO25 updates in #EsophagealCancer & #GastricCancer: ✔️ CheckMate 577 ✔️ Matterhorn ✔️ DESTINY-Gastric04 ✔️ SATRi-cel (CAR-T!) With Lizzy Smyth, Sylvie Lorenzen & @ThAlcin 🎙 Listen now: open.spotify.com/episode/65JSJu… #GIonc

Kohei shitara (@koheishitara) 's Twitter Profile Photo

Happy to share initial report on temporal change of CLDN18.2 after chemo + zolbetuximab: ~50% showed decreased expression (<75%+ cells) on PD, but 75% retained ≥25% expression—supporting potential for other CLDN-targeted tx like ADCs ESMO Open ESMO - Eur. Oncology   sciencedirect.com/science/articl…

Happy to share initial report on temporal change of CLDN18.2 after chemo + zolbetuximab: ~50% showed decreased expression (&lt;75%+ cells) on PD, but 75% retained ≥25% expression—supporting potential for other CLDN-targeted tx like ADCs <a href="/ESMO_Open/">ESMO Open</a> <a href="/myESMO/">ESMO - Eur. Oncology</a>   sciencedirect.com/science/articl…
Jeroen Dekervel (@jdekervel) 's Twitter Profile Photo

🎙️ New #ESMO Podcast – Controversies in Upper GI Cancers 📌 Radiotherapy in borderline resectable #PDAC: Evidence vs practice – when does it make sense? Dr. Nina Niu Sanford & Bas Groot Koerkamp join me to discuss a case & key trials. 🎧 Listen: open.spotify.com/episode/6NFOKd… #PancreaticCancer

AIDA EU project (@aidaeuproject) 's Twitter Profile Photo

🧠An AIDA study reviews advanced AI models to detect Gastric Intestinal Metaplasia, a precancerous condition linked to gastric cancer. Early detection saves lives. AI can help! 👉doi.org/10.48550/arXiv…